Developer docs
API playgroundTry for free, no card

Search company profiles

GenomSys

Full company profile

uuid0003bjr

Namestring
GenomSys
Legal namestring
GenomSys SA
Websiteurl
genomsys.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

GenomSys SA is a Swiss health software company founded in 2016 and headquartered at the EPFL Innovation Park / Biopôle in Lausanne, with additional engineering and operations offices in Lugano, Milan, Turin, and Monza. The company builds and commercializes the only commercial implementation of the ISO/IEC 23092 MPEG-G international standard for genomic data, offering a unified software platform for compression, storage, selective access, transmission, and analysis of genomic information. Its product portfolio comprises the GenomSys MPEG-G Toolkit (SDK and command-line tools), the GenomSys Secondary Analysis Platform (cloud-based germline pipeline), the GenomSys Variant Analyzer (CE-marked desktop variant interpretation software integrated with Varsome), the GenomSys Blood Typer (NGS-based blood group characterization for transfusion medicine), and the GenomYou consumer mobile app for personal genomic data access.

GenomSys monetizes through a mix of one-time enterprise software licensing for the MPEG-G Toolkit, recurring subscriptions for the Variant Analyzer and Blood Typer desktop applications, private cloud deployments for large healthcare organizations, and exclusive regional distribution agreements (e.g., Genetics Company for Biotechnology in Jordan). The company sells via enterprise field sales with quote-based pricing and "Request a Trial" and "Schedule a Call" funnels, complemented by channel partners and OEM integrations with healthcare-IT platforms such as Philips Healthcare. It is ISO 13485-certified as a medical device software manufacturer and targets genomic diagnostic laboratories, blood transfusion centers, and national health systems across Europe, with recent expansion into the Middle East. Strategic technology and research collaborators include EPFL, the Italian Institute of Technology, Varsome, and SysMeta IT/Tangerine Medical. The company is privately held, venture-backed by a CHF 9.3 million Series A (led by Preon Capital in December 2020), and operates with a multicultural team of 11-50 employees.

Short descriptiontext

GenomSys is a Swiss health software company that commercializes the ISO/IEC 23092 MPEG-G standard, offering compression, storage, and analysis software for genomic data to diagnostic labs, blood transfusion centers, and national health systems.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLugano, Switzerland
HQ citystring
Lugano
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
genomic data management, MPEG-G compression software, clinical variant analysis, bioinformatics software platform, medical genomics solutions
Industry3 codes
PRIMARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
SECONDARYHLAAANAL
Population Genomics & Preventive Precision Health Programs
SECONDARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories
NAICS code1 code
  • Software Publishers5132
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Genomic Data Management Software
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1GenomSys MPEG-G Toolkit Licensing
TypeOne Time License
Description

SDK and command-line toolset for encoding, decoding, and managing genomic files in MPEG-G format. Available for on-premises installation and private cloud deployment for organizations implementing the ISO/IEC 23092 standard

genomsys.com
2GenomSys Variant Analyzer Subscription
TypeSubscription Recurring
Description

Clinical variant interpretation software supporting WES and WGS analysis with SNV, indel, and CNV detection, integrated with MPEG-G for end-to-end standard-compliant workflows. Offered as desktop application with trial requests

genomsys.com
3GenomSys Blood Typer Licensing
TypeSubscription Recurring
Description

First-of-its-kind software for genomic blood group characterization based on NGS data for blood transfusion centers - available for clinical testing and validation partnerships

genomsys.com
4Regional Distribution Agreements
TypeLicensing Royalties
Description

Exclusive software distribution partnerships in specific territories (e.g., Jordan with Genetics Company for Biotechnology) for regional market expansion

genomsys.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Enterprise software licensing and subscription model
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based pricing through direct sales engagement. GenomSys Variant Analyzer and Blood Typer available via trial requests. Toolkit offered for on-premises and private cloud deployment.

genomsys.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 5 records shown
1GenomSys MPEG-G Toolkit
Description

SDK and command-line toolset for encoding, decoding, and managing genomic files in MPEG-G format for bioinformatics pipeline integration.

genomsys.com
+4 more records
Core offering1 text field

GenomSys develops and licenses a unified software platform built on the ISO/IEC 23092 MPEG-G international standard for genomic data compression, storage, transmission, and analysis. Its portfolio includes an SDK/toolkit for encoding and decoding MPEG-G files, a cloud-based secondary analysis pipeline, a clinical variant interpretation desktop application, an NGS-based blood group typing software, and a consumer mobile app for personal genomic data access and sharing.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 77% reduction in genomic file size vs BAM (lossless compression)
+2 more records
Product overview1 text field

GenomSys offers a unified MPEG-G-based software platform for genomic data management. The product portfolio consists of the GenomSys MPEG-G Toolkit (core SDK and command-line toolset for encoding/decoding/ managing MPEG-G genomic files), the GenomSys Secondary Analysis Platform (MPEG-G native cloud-based germline pipeline), the GenomSys Variant Analyzer (clinical variant interpretation desktop application for WES/WGS analysis), GenomSys Blood Typer (NGS-based blood group characterization software), and the GenomYou App (consumer genomics mobile application). All products leverage the ISO/IEC 23092 MPEG-G standard, enabling interoperability, dramatic compression (up to 77% smaller file sizes), and selective access to genomic data. The company is ISO-13485-certified as a manufacturer of software for medical devices.

Product and service5 records
1GenomSys MPEG-G Toolkit
CategoryGenomic data compression SDK
Description

SDK and command-line toolset that enables organizations to implement the ISO/IEC 23092 MPEG-G standard for encoding, decoding, and managing genomic sequencing data in their processing workflows, available on-premises and on private cloud.

2GenomSys Secondary Analysis Platform
CategoryCloud-based secondary analysis pipeline
Description

ISO/IEC 23092 MPEG-G native cloud-based germline pipeline that conducts secondary analysis for germline applications and enables automated compression and upload of genomic files directly from sequencing machines for downstream tertiary analysis.

3GenomSys Variant Analyzer (GVA)
CategoryClinical variant interpretation software
Description

Germline analysis software natively operating in MPEG-G that supports Whole Exome Sequencing and Whole Genome Sequencing analysis with SNV, indel, and CNV detection, integrated with Varsome for variant annotation; targeted at clinical genetics laboratories for hereditary disease diagnostics.

4GenomSys Blood Typer
CategoryBlood group genotyping software
Description

First-of-its-kind software for high-throughput genomic characterization of 36 blood groups based on Next-Generation Sequencing data following International Society for Blood Transfusion standards, designed for blood transfusion centers to support transfusion compatibility and organ and stem cell transplantation.

5GenomYou App
CategoryConsumer genomics mobile application
Description

Consumer-facing mobile genomics application that enables individuals to access, understand, and securely share their personal genomic data in standardized MPEG-G format on their smartphones, supporting health and lifestyle decisions through integrated genetic counselling.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-05-01
Description

Exclusive software distribution agreement in Jordan for MPEG-G solutions covering the Middle East region. Partnership focuses on MPEG-G standard adoption, preventive medicine software development, and clinical testing/validation of Blood Typer in Jordanian clinical environment.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic cooperation integrating MPEG-G genomic data management into Philips health informatics portfolio. GenomSys contributes as recognized Healthcare Software Provider enabling hospitals and diagnostic centers to access standardized genomic solutions within enterprise-grade Philips infrastructure.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Joint laboratory collaboration validating MPEG-G on 5000genomi@VdA project with over 5,800 human genomes sequenced across five clinical cohorts. Collaboration includes Whole Genome Sequencing studies including 1,502 Parkinson's disease cases using AI-powered variant prioritization.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Eurostars consortium partner focused on integration of MPEG-G in software suite for exome and genome interpretation.

5Institute of Medical Genomics (IMEGEN)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Eurostars consortium partner - biomedical genetics company providing testing environment for MPEG-G efficacy in medical genomics field.

genomsys.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Eurostars consortium partner - UK institute researching virus diseases of farm animals, introducing MPEG-G in animal science analysis pipeline.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Headquarters at EPFL Innovation Park. Company co-founded with EPFL affiliations. Active in MPEG-G standard development with EPFL contributions.

Strategic tierMinorTypeOthers
Description

Supported by Vaud canton economic development agency. Listed as company supported by Vaud.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Cloud-based genomic data management and analysis platform serving pharma, clinical labs, and national genomics programs. Closely comparable to GenomSys's MPEG-G Toolkit and Secondary Analysis Platform in offering standards- and pipeline-oriented infrastructure for genomic data at scale.

TypeDirect peer
Description

Bioinformatics platform providing secondary and tertiary analysis pipelines for clinical and research genomics customers. Direct comparable in delivering genomic analysis software into clinical labs and population genomics initiatives, similar go-to-market to GenomSys.

TypeDirect peer
Description

Clinical genomics platform specializing in germline and somatic variant interpretation (exome/genome). Listed as a GenomSys Eurostars consortium partner integrating MPEG-G, and is the most direct head-to-head competitor for the GenomSys Variant Analyzer in hereditary disease diagnostics.

TypeDirect peer
Description

AI-powered clinical genomics platform used by hospital labs for somatic and germline variant interpretation. Direct comparable in selling clinical decision-support software into diagnostic laboratories globally, though at a significantly larger scale.

TypeDirect peer
Description

Federated genomics and biomedical data analysis platform serving pharma, research consortia, and national genomics programs. Comparable in its focus on scalable, secure genomic data infrastructure — overlapping with GenomSys's secondary analysis and national health system play.

TypeDirect peer
Description

Genomic data management and biobanking platform serving national health systems, pharma, and research networks. Comparable in targeting population genomics and standardized genomic data infrastructure for large healthcare systems.

TypeBroad incumbent
Description

Dominant sequencing platform vendor with DRAGEN secondary analysis and other software offerings that compete with GenomSys's Secondary Analysis Platform and Toolkit across most clinical and research genomics customers.

TypeEmerging player
Description

Clinical genomics interpretation platform focused on rare disease and hereditary disease variant analysis. Comparable to the GenomSys Variant Analyzer use case in hereditary diagnostics, though with a narrower commercial footprint.

TypeEmerging player
Description

Clinical genomic analysis platform for rare disease and hereditary disorder interpretation, used by national genomics programs. Comparable to GenomSys Variant Analyzer in germline analysis for hereditary diagnostics.

TypeEmerging player
Description

Genomics and AI-driven phenotyping platform integrating facial and genomic analysis for rare disease diagnosis. Adjacent player serving similar diagnostic laboratory customers with complementary genomics-based decision support.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors8 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

GenomSys

Genomic Data Management Softwaregenomsys.com

GenomSys is a Swiss health software company that commercializes the ISO/IEC 23092 MPEG-G standard, offering compression, storage, and analysis software for genomic data to diagnostic labs, blood transfusion centers, and national health systems.

What GenomSys does

GenomSys SA is a Swiss health software company founded in 2016 and headquartered at the EPFL Innovation Park / Biopôle in Lausanne, with additional engineering and operations offices in Lugano, Milan, Turin, and Monza. The company builds and commercializes the only commercial implementation of the ISO/IEC 23092 MPEG-G international standard for genomic data, offering a unified software platform for compression, storage, selective access, transmission, and analysis of genomic information. Its product portfolio comprises the GenomSys MPEG-G Toolkit (SDK and command-line tools), the GenomSys Secondary Analysis Platform (cloud-based germline pipeline), the GenomSys Variant Analyzer (CE-marked desktop variant interpretation software integrated with Varsome), the GenomSys Blood Typer (NGS-based blood group characterization for transfusion medicine), and the GenomYou consumer mobile app for personal genomic data access.

GenomSys monetizes through a mix of one-time enterprise software licensing for the MPEG-G Toolkit, recurring subscriptions for the Variant Analyzer and Blood Typer desktop applications, private cloud deployments for large healthcare organizations, and exclusive regional distribution agreements (e.g., Genetics Company for Biotechnology in Jordan). The company sells via enterprise field sales with quote-based pricing and "Request a Trial" and "Schedule a Call" funnels, complemented by channel partners and OEM integrations with healthcare-IT platforms such as Philips Healthcare. It is ISO 13485-certified as a medical device software manufacturer and targets genomic diagnostic laboratories, blood transfusion centers, and national health systems across Europe, with recent expansion into the Middle East. Strategic technology and research collaborators include EPFL, the Italian Institute of Technology, Varsome, and SysMeta IT/Tangerine Medical. The company is privately held, venture-backed by a CHF 9.3 million Series A (led by Preon Capital in December 2020), and operates with a multicultural team of 11-50 employees.

GenomSys firmographics

Firmographics
Name
GenomSys
Legal name
GenomSys SA
Website
https://genomsys.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
1–10 employees
Short description
GenomSys is a Swiss health software company that commercializes the ISO/IEC 23092 MPEG-G standard, offering compression, storage, and analysis software for genomic data to diagnostic labs, blood transfusion centers, and national health systems.
Ownership category
akta.pro rank

GenomSys industry classification

Industry
Product category
Genomic Data Management Software
NAICS
Software Publishers (5132)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
SECONDARYHLAAANAL
Population Genomics & Preventive Precision Health Programs
SECONDARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories

Keywords

  • Genomic data management
  • MPEG-G compression software
  • Clinical variant analysis
  • Bioinformatics software platform
  • Medical genomics solutions

Where GenomSys is headquartered

Location

Headquarters

HQ city
Lugano
HQ country
Switzerland
HQ region
Europe

Offices5 records

Markets served

GenomSys business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. GenomSys MPEG-G Toolkit Licensing: SDK and command-line toolset for encoding, decoding, and managing genomic files in MPEG-G format. Available for on-premises installation and private cloud deployment for organizations implementing the ISO/IEC 23092 standard
  2. GenomSys Variant Analyzer Subscription: Clinical variant interpretation software supporting WES and WGS analysis with SNV, indel, and CNV detection, integrated with MPEG-G for end-to-end standard-compliant workflows. Offered as desktop application with trial requests
  3. GenomSys Blood Typer Licensing: First-of-its-kind software for genomic blood group characterization based on NGS data for blood transfusion centers - available for clinical testing and validation partnerships
  4. Regional Distribution Agreements: Exclusive software distribution partnerships in specific territories (e.g., Jordan with Genetics Company for Biotechnology) for regional market expansion

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise software licensing and subscription model

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

GenomSys product offering

Product offering

Core offering

GenomSys develops and licenses a unified software platform built on the ISO/IEC 23092 MPEG-G international standard for genomic data compression, storage, transmission, and analysis. Its portfolio includes an SDK/toolkit for encoding and decoding MPEG-G files, a cloud-based secondary analysis pipeline, a clinical variant interpretation desktop application, an NGS-based blood group typing software, and a consumer mobile app for personal genomic data access and sharing.

Product overview

GenomSys offers a unified MPEG-G-based software platform for genomic data management. The product portfolio consists of the GenomSys MPEG-G Toolkit (core SDK and command-line toolset for encoding/decoding/ managing MPEG-G genomic files), the GenomSys Secondary Analysis Platform (MPEG-G native cloud-based germline pipeline), the GenomSys Variant Analyzer (clinical variant interpretation desktop application for WES/WGS analysis), GenomSys Blood Typer (NGS-based blood group characterization software), and the GenomYou App (consumer genomics mobile application). All products leverage the ISO/IEC 23092 MPEG-G standard, enabling interoperability, dramatic compression (up to 77% smaller file sizes), and selective access to genomic data. The company is ISO-13485-certified as a manufacturer of software for medical devices.

Differentiator

Problem solved

Functional benefit

Brands

  • GenomSys MPEG-G Toolkit: SDK and command-line toolset for encoding, decoding, and managing genomic files in MPEG-G format for bioinformatics pipeline integration.
  • GenomSys Variant Analyzer
  • GenomSys Blood Typer
  • GenomSys Secondary Analysis
  • GenomYou

Products and services

  • GenomSys MPEG-G Toolkit SDK and command-line toolset that enables organizations to implement the ISO/IEC 23092 MPEG-G standard for encoding, decoding, and managing genomic sequencing data in their processing workflows, available on-premises and on private cloud.
  • GenomSys Secondary Analysis Platform ISO/IEC 23092 MPEG-G native cloud-based germline pipeline that conducts secondary analysis for germline applications and enables automated compression and upload of genomic files directly from sequencing machines for downstream tertiary analysis.
  • GenomSys Variant Analyzer (GVA) Germline analysis software natively operating in MPEG-G that supports Whole Exome Sequencing and Whole Genome Sequencing analysis with SNV, indel, and CNV detection, integrated with Varsome for variant annotation; targeted at clinical genetics laboratories for hereditary disease diagnostics.
  • GenomSys Blood Typer First-of-its-kind software for high-throughput genomic characterization of 36 blood groups based on Next-Generation Sequencing data following International Society for Blood Transfusion standards, designed for blood transfusion centers to support transfusion compatibility and organ and stem cell transplantation.
  • GenomYou App Consumer-facing mobile genomics application that enables individuals to access, understand, and securely share their personal genomic data in standardized MPEG-G format on their smartphones, supporting health and lifestyle decisions through integrated genetic counselling.

Quantifiable outcome

  • 77% reduction in genomic file size vs BAM (lossless compression)
  • +2 more outcomes

Companies that use GenomSys

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles5 records

GenomSys technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

Feature6 records

GenomSys partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and minor.

  • Genetics Company for BiotechnologycoreChannel Partner/ Reseller/ Distributor · 1 May 2026Exclusive software distribution agreement in Jordan for MPEG-G solutions covering the Middle East region. Partnership focuses on MPEG-G standard adoption, preventive medicine software development, and clinical testing/validation of Blood Typer in Jordanian clinical environment.
  • Philips HealthcarecoreStrategic or Co-development PartnerStrategic cooperation integrating MPEG-G genomic data management into Philips health informatics portfolio. GenomSys contributes as recognized Healthcare Software Provider enabling hospitals and diagnostic centers to access standardized genomic solutions within enterprise-grade Philips infrastructure.
  • Italian Institute of Technology (IIT)coreStrategic or Co-development PartnerJoint laboratory collaboration validating MPEG-G on 5000genomi@VdA project with over 5,800 human genomes sequenced across five clinical cohorts. Collaboration includes Whole Genome Sequencing studies including 1,502 Parkinson's disease cases using AI-powered variant prioritization.
  • SeqOneminorStrategic or Co-development PartnerEurostars consortium partner focused on integration of MPEG-G in software suite for exome and genome interpretation.
  • Institute of Medical Genomics (IMEGEN)minorStrategic or Co-development PartnerEurostars consortium partner - biomedical genetics company providing testing environment for MPEG-G efficacy in medical genomics field.
  • The Pirbright InstituteminorStrategic or Co-development PartnerEurostars consortium partner - UK institute researching virus diseases of farm animals, introducing MPEG-G in animal science analysis pipeline.
  • EPFLcoreStrategic or Co-development PartnerHeadquarters at EPFL Innovation Park. Company co-founded with EPFL affiliations. Active in MPEG-G standard development with EPFL contributions.
  • Vaud Economic DevelopmentminorOthersSupported by Vaud canton economic development agency. Listed as company supported by Vaud.

Scale indicators6 records

Recent moves8 records

Expansion highlights5 records

GenomSys competitors and assessment

Company assessment

Direct peers

  • DNAnexus: Cloud-based genomic data management and analysis platform serving pharma, clinical labs, and national genomics programs. Closely comparable to GenomSys's MPEG-G Toolkit and Secondary Analysis Platform in offering standards- and pipeline-oriented infrastructure for genomic data at scale.
  • Velsera (formerly Seven Bridges Genomics): Bioinformatics platform providing secondary and tertiary analysis pipelines for clinical and research genomics customers. Direct comparable in delivering genomic analysis software into clinical labs and population genomics initiatives, similar go-to-market to GenomSys.
  • SeqOne: Clinical genomics platform specializing in germline and somatic variant interpretation (exome/genome). Listed as a GenomSys Eurostars consortium partner integrating MPEG-G, and is the most direct head-to-head competitor for the GenomSys Variant Analyzer in hereditary disease diagnostics.
  • Sophia Genetics: AI-powered clinical genomics platform used by hospital labs for somatic and germline variant interpretation. Direct comparable in selling clinical decision-support software into diagnostic laboratories globally, though at a significantly larger scale.
  • Lifebit: Federated genomics and biomedical data analysis platform serving pharma, research consortia, and national genomics programs. Comparable in its focus on scalable, secure genomic data infrastructure — overlapping with GenomSys's secondary analysis and national health system play.
  • BC Platforms: Genomic data management and biobanking platform serving national health systems, pharma, and research networks. Comparable in targeting population genomics and standardized genomic data infrastructure for large healthcare systems.

Broad incumbents

  • Illumina (DRAGEN): Dominant sequencing platform vendor with DRAGEN secondary analysis and other software offerings that compete with GenomSys's Secondary Analysis Platform and Toolkit across most clinical and research genomics customers.

Emerging players

  • Fabric Genomics (formerly Omicia): Clinical genomics interpretation platform focused on rare disease and hereditary disease variant analysis. Comparable to the GenomSys Variant Analyzer use case in hereditary diagnostics, though with a narrower commercial footprint.
  • Congenica: Clinical genomic analysis platform for rare disease and hereditary disorder interpretation, used by national genomics programs. Comparable to GenomSys Variant Analyzer in germline analysis for hereditary diagnostics.
  • FDNA: Genomics and AI-driven phenotyping platform integrating facial and genomic analysis for rare disease diagnosis. Adjacent player serving similar diagnostic laboratory customers with complementary genomics-based decision support.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

GenomSys social profiles

Digital presence

GenomSys compliance and trust

Trust signal

Compliance1 record

GenomSys financial estimates

Financial estimate

Revenue estimate

Valuation estimate

GenomSys leadership team

Management profile

Number of profiles

Profiles4 records

GenomSys subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

GenomSys funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

GenomSys M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GenomSys

What does GenomSys do?

GenomSys develops and licenses a unified software platform built on the ISO/IEC 23092 MPEG-G international standard for genomic data compression, storage, transmission, and analysis. Its portfolio includes an SDK/toolkit for encoding and decoding MPEG-G files, a cloud-based secondary analysis pipeline, a clinical variant interpretation desktop application, an NGS-based blood group typing software, and a consumer mobile app for personal genomic data access and sharing.

Is GenomSys a public or private company?

GenomSys is a private company. It is classified as venture growth investor backed and is currently operating.

When was GenomSys founded?

GenomSys was founded in 2016. It employs 1 to 10 people.

Where is GenomSys based?

GenomSys is headquartered in Lugano, Switzerland, in the Europe region.

How does GenomSys make money?

Four revenue lines are on record. GenomSys MPEG-G Toolkit Licensing is the primary driver. The others are genomSys Variant Analyzer Subscription, genomSys Blood Typer Licensing and regional Distribution Agreements.

Who are GenomSys's main competitors?

Direct peers on record are DNAnexus, Velsera (formerly Seven Bridges Genomics), SeqOne, Sophia Genetics, Lifebit and BC Platforms. Illumina (DRAGEN) is listed as a broad incumbent. Emerging players are Fabric Genomics (formerly Omicia), Congenica and FDNA.

Does GenomSys have an API?

No public API is recorded for GenomSys.

What industry is GenomSys in?

GenomSys's product category is Genomic Data Management Software. Its primary akta.pro industry code is HLAAALAD, Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics), with a secondary code of HLAAANAL, Population Genomics & Preventive Precision Health Programs. Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
startupticker.chCE-marked GenomSys Variant Analyzer launchedGenomSys launched and CE-marked its GenomSys Variant Analyzer, the first genomic analysis software running natively on the MPEG-G ISO standard. The tool integrates Varsom variant databases and aims to simplify genomic analysis for geneticists. The company also released a Codec Suite in April to convert legacy formats to MPEG-G.startupticker.chGenomSys and Philips join forces for novel genomic analysis solutionsGenomSys signed a multi-year development and license agreement with Philips to create MPEG-G compliant genomic analysis tools. Philips will integrate GenomSys' software into its platforms, and GenomSys receives a sole license to Philips' MPEG-G patents. The collaboration targets diagnostic and treatment applications, especially oncology.startupticker.chCE Mark for GenomSys’ software tools for genomic data processingGenomSys' MPEG-G Codec Suite for genomic data processing has received CE marking as an in-vitro diagnostic medical device, enabling clinical-grade use. The suite compresses whole-genome files to under 25% of legacy size and cuts processing time by over 89%.startupticker.chNew CEOs for ambitious start-upsGamaya, Valour, Genomsys, Sophia Genetics, and Involi have appointed new CEOs or C-level executives. Igor Ivanov became CEO of Gamaya, Diana Biggs leads Valour, Alessio Ascari heads Genomsys, Ross Muken joins Sophia Genetics as CFO, and Raphael Zaugg becomes Involi's CTO. Valour is near $30m in assets under management.Corriere della SeraFilmati sul genoma, un futuro con il Dna sul cellulareBuono and De Negri invested 8.5 million euros in Swiss startup GenomSys, which develops software to compress and share DNA data like video files. The company aims to let doctors access genomic information via smartphones for personalized treatments. The technology follows the MPEG standard for genomic data.BeBeezI family office di Stefano Buono e Michele De Negri , insieme al Club degli Investitori, partecipano al round della svizzera GenomSys - BeBeezGenomSys, a Swiss DNA data processing software company founded in 2016, developed a technology for efficient DNA data processing and sharing. Its products conform to the MPEG-G ISO standard for genomic data representation, reducing storage costs and transfer times.